Cargando…
Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Bilateral kidney ligation of mice immediately before injection of misonidazole (MIS) prolongs the plasma half-life of this radiosensitizer from about 2 h (in normal mice) to 10-11 h, similar to that in man. Kidney ligation does not, however, change the relative proportions of MIS and its O-demethyla...
Autores principales: | Brown, J. M., Yu, N. Y., Workman, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009863/ https://www.ncbi.nlm.nih.gov/pubmed/465300 |
Ejemplares similares
-
Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-9963) in dogs
por: White, R. A. S., et al.
Publicado: (1980) -
Modest radiosensitization of solid tumours in C3H mice by the hypoxic cell radiosensitizer NDPP.
por: Sheldon, P. W., et al.
Publicado: (1975) -
Radiosensitizers of Hypoxic Cells
por: Nias, A. H. W.
Publicado: (1980) -
Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.
por: Workman, P., et al.
Publicado: (1980) -
Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.
por: Sheldon, P. W., et al.
Publicado: (1977)